Successful Lung Transplant for Norway’s Crown Princess
Norway s crown princess undergoes successful – Norway’s crown princess undergoes a successful lung transplant, a milestone achieved on June 17, 2026, as confirmed by the Norwegian royal family. The procedure, conducted at Oslo University Hospital, marks a pivotal moment in the treatment of Crown Princess Mette-Marit, who has been living with a progressive lung condition for several years. The palace released a statement expressing relief and optimism, stating that the surgery was completed without complications and that the princess is now entering the recovery phase. This development has generated widespread public interest, with many hoping to see her regain her health and continue her role in the royal family.
Diagnosis and the Path to Transplant
Crown Princess Mette-Marit was diagnosed with pulmonary fibrosis in 2018, a condition that causes scarring of the lung tissue and leads to progressive breathing difficulties. By early June 2026, her health had deteriorated significantly, prompting her to join the transplant waiting list. Medical professionals at Oslo University Hospital emphasized that her condition had progressed to a critical stage, where a year of life without surgery was uncertain. The decision to proceed with a lung transplant was made after extensive consultations with her doctors and the royal family, underscoring the urgency of the situation.
“The crown princess will require several weeks of hospital care to ensure proper recovery,” said Professor Are Holm from Oslo University Hospital, as shared by the palace. The professor added that the transplant team had prepared thoroughly to manage potential complications, and the princess’s overall health had been a key factor in the successful outcome.
Family Challenges and Public Attention
Amid the celebration of her health improvement, the Norwegian royal family faces ongoing challenges. Just days before the transplant, Crown Princess Mette-Marit’s son, Marius Borg Hoiby, was convicted of rape and domestic violence, receiving a four-year prison sentence. The trial, which dominated media coverage, occurred in the same week as the announcement of his mother’s transplant, drawing comparisons between the personal and public trials the royal family has endured. The timing of these events has sparked discussions about the impact of personal scandals on the monarchy’s image.
Crown Prince Haakon, who has been a steadfast supporter of his wife’s health journey, shared updates about her condition in December 2025. He mentioned that Mette-Marit’s breathing difficulties had intensified, signaling the need for urgent medical action. The royal couple expressed gratitude for the public’s continued support, stating that their next update would follow her hospital discharge. This sentiment reflects the close-knit relationship between the monarchy and its citizens, who have often rallied around the family during difficult times.
Monarchy Approval and Public Sentiment
The crown princess’s transplant has also been viewed as a positive sign for Norway’s monarchy, which saw its approval ratings dip during the trial of her son. A Norstat survey conducted in February 2026 revealed that public approval of the monarchy reached a record low of 60%, but by May, it had slightly rebounded to 64%. This uptick may be linked to the princess’s health recovery, as her resilience has been celebrated by many as a symbol of hope and determination.
Despite the challenges, Norway’s crown princess undergoes her transplant with the support of the royal family and the Norwegian people. Her journey began in 1999 as an unmarried commoner and single mother, who met Crown Prince Haakon at a music festival. Their relationship, which captured the public’s imagination, has been a cornerstone of the monarchy’s visibility. Now, with her health on the mend, the princess’s story continues to inspire.
Recovery and the Road Ahead
Following the transplant, Mette-Marit is expected to require several weeks of hospital care to stabilize her condition. During this time, she will undergo regular check-ups and monitor her recovery progress closely. The Oslo University Hospital has assured the public that the princess’s post-operative care is being managed with the utmost care, including specialized respiratory therapy and nutritional support. As she transitions to the recovery phase, the palace has emphasized the importance of rest and gradual reintegration into daily activities.
While the focus remains on her health, the royal family has also acknowledged the broader implications of her transplant. Prime Minister Jonas Gahr Stoere praised Mette-Marit for her openness about her illness, calling her story an inspiration to others facing similar challenges. Her experience highlights the intersection of personal health, public life, and the resilience required to navigate both. As she begins her recovery, the Norwegian monarchy looks forward to continuing its role in the nation’s cultural and social fabric.
